MHRA-2022-0008-V408

Type II variation for application MHRA-2022-0008. Type II variation: New Dosage Strength for Pancrelipaze-R — major revision

Variation Number
MHRA-2022-0008-V408
Type
Type II
Application
MHRA-2022-0008
Change
CHG-2021-0108
Status
In Progress
Fee
€62,676
Submitted
2023-03-16
Approved
—
Description

Type II variation: New Dosage Strength for Pancrelipaze-R — major revision